N-[[(2S,4S)-1-[2-(dimethylamino)pyrimidin-4-yl]-4-fluoropyrrolidin-2-yl]methyl]-1,3-thiazole-4-carboxamide
C15H19FN6OS — CID 128994041
Data last refreshed: (MolForge compound catalog, from PubChem)
About N-[[(2S,4S)-1-[2-(dimethylamino)pyrimidin-4-yl]-4-fluoropyrrolidin-2-yl]methyl]-1,3-thiazole-4-carboxamide
N-[[(2S,4S)-1-[2-(dimethylamino)pyrimidin-4-yl]-4-fluoropyrrolidin-2-yl]methyl]-1,3-thiazole-4-carboxamide (PubChem CID 128994041) has the molecular formula C15H19FN6OS and a molecular weight of 350.42 g/mol. Its IUPAC name is N-[[(2S,4S)-1-[2-(dimethylamino)pyrimidin-4-yl]-4-fluoropyrrolidin-2-yl]methyl]-1,3-thiazole-4-carboxamide.
Molecular Properties
| Compound Name | N-[[(2S,4S)-1-[2-(dimethylamino)pyrimidin-4-yl]-4-fluoropyrrolidin-2-yl]methyl]-1,3-thiazole-4-carboxamide |
|---|---|
| PubChem CID | 128994041 |
| Molecular Formula | C15H19FN6OS |
| Molecular Weight | 350.42 g/mol |
| Exact Mass | 350.13 |
| IUPAC Name | N-[[(2S,4S)-1-[2-(dimethylamino)pyrimidin-4-yl]-4-fluoropyrrolidin-2-yl]methyl]-1,3-thiazole-4-carboxamide |
| SMILES | CN(C)c1nccc(N2C[C@@H](F)C[C@H]2CNC(=O)c2cscn2)n1 |
| InChI | InChI=1S/C15H19FN6OS/c1-21(2)15-17-4-3-13(20-15)22-7-10(16)5-11(22)6-18-14(23)12-8-24-9-19-12/h3-4,8-11H,5-7H2,1-2H3,(H,18,23)/t10-,11-/m0/s1 |
| InChIKey | KVKSGAVWOLINDI-QWRGUYRKSA-N |
| XLogP | 1.35 |
| TPSA | 74.25 Ų |
| H-Bond Donors | 1 |
| H-Bond Acceptors | 7 |
| Rotatable Bonds | 5 |
| Heavy Atoms | 24 |
| Complexity | — |
Lipinski Rule of Five
Passes Rule of Five
| Rule | Value |
|---|---|
| MW ≤ 500 | 350.42 |
| LogP ≤ 5 | 1.35 |
| H-Bond Donors ≤ 5 | 1 |
| H-Bond Acceptors ≤ 10 | 7 |
Frequently Asked Questions
Browse: Molecules A–Z · all molecules A–Z · drugs A–Z · protein targets A–Z.
Sources
- PubChem CID 128994041 — identifiers, structure, computed properties (public domain)
How this page is built: methodology · editorial policy & corrections.
For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.